These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 26486739

  • 21. The prevalence of CALR mutations in a cohort of patients with myeloproliferative neoplasms.
    Grinsztejn E, Percy MJ, McClenaghan D, Quintana M, Cuthbert RJ, McMullin MF.
    Int J Lab Hematol; 2016 Feb; 38(1):102-6. PubMed ID: 26555437
    [Abstract] [Full Text] [Related]

  • 22. The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia.
    Wang J, Hao J, He N, Ji C, Ma D.
    Turk J Haematol; 2016 Sep 05; 33(3):180-6. PubMed ID: 26377485
    [Abstract] [Full Text] [Related]

  • 23. Somatic mutations of calreticulin in myeloproliferative neoplasms.
    Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D, Chen D, Vladimer GI, Bagienski K, Milanesi C, Casetti IC, Sant'Antonio E, Ferretti V, Elena C, Schischlik F, Cleary C, Six M, Schalling M, Schönegger A, Bock C, Malcovati L, Pascutto C, Superti-Furga G, Cazzola M, Kralovics R.
    N Engl J Med; 2013 Dec 19; 369(25):2379-90. PubMed ID: 24325356
    [Abstract] [Full Text] [Related]

  • 24. CALR mutation profile in Irish patients with myeloproliferative neoplasms.
    Haslam K, Conneally E, Flynn CM, Cahill MR, Gilligan O, O'Shea D, Langabeer SE.
    Hematol Oncol Stem Cell Ther; 2016 Sep 19; 9(3):112-5. PubMed ID: 27352261
    [Abstract] [Full Text] [Related]

  • 25. Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring.
    Chi J, Manoloukos M, Pierides C, Nicolaidou V, Nicolaou K, Kleopa M, Vassiliou G, Costeas P.
    Ann Hematol; 2015 Mar 19; 94(3):399-408. PubMed ID: 25349114
    [Abstract] [Full Text] [Related]

  • 26. Peptide nucleic acid probe-based fluorescence melting curve analysis for rapid screening of common JAK2, MPL, and CALR mutations.
    Park J, Song M, Jang W, Chae H, Lee GD, Kim K, Park H, Kim M, Kim Y.
    Clin Chim Acta; 2017 Feb 19; 465():82-90. PubMed ID: 27939919
    [Abstract] [Full Text] [Related]

  • 27. Pyrosequencing-based quantitative measurement of CALR mutation allele burdens and their clinical implications in patients with myeloproliferative neoplasms.
    Oh Y, Song IC, Kim J, Kwon GC, Koo SH, Kim SY.
    Clin Chim Acta; 2018 Aug 19; 483():183-191. PubMed ID: 29727699
    [Abstract] [Full Text] [Related]

  • 28. Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms.
    Guo H, Chen X, Tian R, Chang J, Li J, Tan Y, Xu Z, Ren F, Zhao J, Pan J, Zhang N, Wang X, He J, Yang W, Wang H.
    PLoS One; 2015 Aug 19; 10(9):e0138250. PubMed ID: 26375990
    [Abstract] [Full Text] [Related]

  • 29. Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations.
    Yang HS.
    Cancer Biomark; 2016 Aug 19; 17(4):383-389. PubMed ID: 27662324
    [Abstract] [Full Text] [Related]

  • 30. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ, Berneman Z, Schroyens W, De Raeve H.
    Acta Haematol; 2015 Aug 19; 133(1):36-51. PubMed ID: 25116092
    [Abstract] [Full Text] [Related]

  • 31. Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysis.
    Lim KH, Lin HC, Chen CG, Wang WT, Chang YC, Chiang YH, Lin CS, Su NW, Su YW, Lin J, Chang YF, Chang MC, Hsieh RK, Kuo YY, Chou WC.
    Clin Chim Acta; 2015 Feb 02; 440():133-9. PubMed ID: 25447704
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Rapid detection of CALR type 1 and type 2 mutations using PNA-LNA clamping loop-mediated isothermal amplification on a CD-like microfluidic chip.
    Cao G, Kong J, Xing Z, Tang Y, Zhang X, Xu X, Kang Z, Fang X, Guan M.
    Anal Chim Acta; 2018 Sep 18; 1024():123-135. PubMed ID: 29776538
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms.
    Jones AV, Ward D, Lyon M, Leung W, Callaway A, Chase A, Dent CL, White HE, Drexler HG, Nangalia J, Mattocks C, Cross NC.
    Leuk Res; 2015 Jan 18; 39(1):82-7. PubMed ID: 25499808
    [Abstract] [Full Text] [Related]

  • 36. Rapid and sensitive detection of calreticulin type 1 and 2 mutations by real-time quantitative PCR.
    Zinke M, Nageswaran V, Reinhardt R, Burmeister T.
    Mol Diagn Ther; 2015 Oct 18; 19(5):329-34. PubMed ID: 26294037
    [Abstract] [Full Text] [Related]

  • 37. [Detection of JAK2V617F and CALR Gene Mutations by Multiplex of Patients with Myeloproliferative Neoplasms PCR-Capillary Electrophoresis].
    Yuan JL, Shi YX, DU H, Wang YJ, Zhao ZL, Li G, Han YQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec 18; 28(6):1998-2003. PubMed ID: 33283732
    [Abstract] [Full Text] [Related]

  • 38. [JAK2 exon 12 mutations in patients with Philadelphia (Ph) chromosome-negative myeloproliferative neoplasms].
    Wang JY, Ai XF, Xu JQ, Li QH, Xu ZF, Qin TJ, Zang Y, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Sep 18; 33(9):705-9. PubMed ID: 23336221
    [Abstract] [Full Text] [Related]

  • 39. Pitfalls of using polymerase chain reaction-based assays for JAK2 and CALR exon 9 variant testing in myeloproliferative neoplasms: Knowing when to go the extra mile!
    Krishnamurthy K, Chai J, Wang Y, Naeem R, Goldstein DY.
    Am J Clin Pathol; 2024 Feb 01; 161(2):155-161. PubMed ID: 37788380
    [Abstract] [Full Text] [Related]

  • 40. Calreticulin Mutations in Myeloproliferative Neoplasms: Comparison of Three Diagnostic Methods.
    Park JH, Sevin M, Ramla S, Truffot A, Verrier T, Bouchot D, Courtois M, Bas M, Benali S, Bailly F, Favre B, Guy J, Martin L, Maynadié M, Carillo S, Girodon F.
    PLoS One; 2015 Feb 01; 10(10):e0141010. PubMed ID: 26501981
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.